(Q71076705)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8629589%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

title

Combined alpha-beta blockade (doxazosin plus metoprolol) compared with beta blockade alone in chronic congestive heart failure (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8629589%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

main subject

congestive heart failure

1 reference

M L Kukin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8629589%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

J Kalman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8629589%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

M Mannino

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8629589%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

R Freudenberger

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8629589%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

C Buchholz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8629589%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

O Ocampo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8629589%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

language of work or name

English

0 references

publication date

1 March 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8629589%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Cardiology

16 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8629589%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

volume

77

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8629589%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

page(s)

486-491

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8629589%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8629589%20AND%20SRC:MED&resulttype=core&format=json

Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy

16 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989342-3

Long-term beta-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindolol versus placebo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989342-3

Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989342-3

Prolongation of survival in congestive cardiomyopathy by beta-receptor blockade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989342-3

Increased beta-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989342-3

Beneficial effects of long-term beta-blockade in congestive cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989342-3

Exercise hemodynamics and myocardial metabolism during long-term beta-adrenergic blockade in severe heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989342-3

Oral beta-adrenergic blockade with metoprolol in chronic severe dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989342-3

The paradox of beta-adrenergic blockade for the management of congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989342-3

Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989342-3

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989342-3

New alpha 1-adrenergic receptor antagonists for the treatment of hypertension: role of vascular alpha receptors in the control of peripheral resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989342-3

Doxazosin for the treatment of chronic congestive heart failure: Results of a randomized double-blind and placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989342-3

Role of the renin-angiotensin system in the development of hemodynamic and clinical tolerance to long-term prazosin therapy in patients with severe chronic heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989342-3

Multicenter clinical evaluation of long-term efficacy and safety of labetalol in treatment of hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989342-3

Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989342-3

Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989342-3

Hemodynamic changes mimicking a vasodilator drug response in the absence of drug therapy after right heart catheterization in patients with chronic heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989342-3

Sustained hemodynamic response to flosequinan in patients with heart failure receiving angiotensin-converting enzyme inhibitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989342-3

Flosequinan, a new vasodilator: systemic and coronary hemodynamics and neuroendocrine effects in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989342-3

Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989342-3

10.1016/S0002-9149(97)89342-3

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8629589%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

1 reference